GIM
SNY icon

Glenmede Investment Management’s Sanofi SNY Stock Holding History

Glenmede Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.78M Sell
58,958
-6,658
-10% -$321K 0.01% 516
2025
Q2 		$3.17M Buy
+65,616
New +$3.35M 0.02% 508

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Glenmede Investment Management's SNY Position: Q3 2025 in Review

Glenmede Investment Management reduced its Sanofi (SNY) stake by 10% in Q3 2025, selling an estimated $321K and leaving 58,958 shares worth $2.78M. The position accounts for 0.01% of the portfolio, ranked #516.

Glenmede Investment Management first reported a position in SNY in Q2 2025 and has held it in 2 quarters since. The position peaked at $3.17M in Q2 2025. 711 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Glenmede Investment Management held 58,958 shares of Sanofi worth $2.78M as of Q3 2025.
  • Glenmede Investment Management sold 6,658 Sanofi shares in Q3 2025, an estimated $321K.
  • Sanofi made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #516 holding.
  • Glenmede Investment Management first reported a position in Sanofi in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Sanofi position peaked at $3.17M in Q2 2025.
  • 711 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.